B12 Injection vs Semax
A side-by-side research comparison of B12 Injection and Semax across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | B12 Injection | Semax |
|---|---|---|
| Full name | Methylcobalamin (Vitamin B12) Injectable | Semax (ACTH 4-10 analog) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Prescribed / OTC | Research compound |
| Mechanism | Cofactor for methionine synthase (DNA methylation) and methylmalonyl-CoA mutase (energy metabolism). Supports myelin synthesis, neurotransmitter production, and red blood cell formation. | Activates MC3/4R, increases BDNF and NGF, modulates dopamine/serotonin, enhances neuronal survival via TrkB, and promotes CREB-mediated neuroplasticity. |
| Molecular weight | 1344.38 Da | 813.9 Da |
| Half-life | ~6 days | 3-5 min (systemic) / extended (intranasal) |
| Bioavailability | ~100% IM/SC | Moderate (intranasal) |
| Typical dose | 1000-5000 mcg | 200-600 mcg per dose |
| Frequency | 1-3x per week | 2-3x daily |
| Route | Intramuscular or subcutaneous injection | Intranasal drops/spray |
B12 Injection reported benefits
- Increased energy
- Improved cognitive function
- Nerve repair
- Red blood cell production
- Better sleep
- Mood enhancement
Semax reported benefits
- Enhanced attention/focus
- Memory improvement
- Neuroprotection (stroke)
- BDNF/NGF upregulation
- Improved learning
- Optic nerve support
Related comparisons
Research and educational reference only. Not medical advice.